The Chlamydia trachomatis IncM Protein Interferes with Host Cell Cytokinesis, Centrosome Positioning, and Golgi Distribution and Contributes to the Stability of the Pathogen-Containing Vacuole.


Journal

Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127

Informations de publication

Date de publication:
18 04 2023
Historique:
medline: 20 4 2023
pubmed: 7 3 2023
entrez: 6 3 2023
Statut: ppublish

Résumé

Chlamydia trachomatis is an obligate intracellular bacterial pathogen that causes ocular and urogenital infections in humans. The ability of C. trachomatis to grow intracellularly in a pathogen-containing vacuole (known as an inclusion) depends on chlamydial effector proteins transported into the host cell by a type III secretion system. Among these effectors, several inclusion membrane proteins (Incs) insert in the vacuolar membrane. Here, we show that human cell lines infected by a C. trachomatis strain deficient for Inc CT288/CTL0540 (renamed IncM) displayed less multinucleation than when infected by IncM-producing strains (wild type or complemented). This indicated that IncM is involved in the ability of Chlamydia to inhibit host cell cytokinesis. The capacity of IncM to induce multinucleation in infected cells was shown to be conserved among its chlamydial homologues and appeared to require its two larger regions predicted to be exposed to the host cell cytosol. C. trachomatis-infected cells also displayed IncM-dependent defects in centrosome positioning, Golgi distribution around the inclusion, and morphology and stability of the inclusion. The altered morphology of inclusions containing IncM-deficient C. trachomatis was further affected by depolymerization of host cell microtubules. This was not observed after depolymerization of microfilaments, and inclusions containing wild-type C. trachomatis did not alter their morphology upon depolymerization of microtubules. Overall, these findings suggest that IncM may exert its effector function by acting directly or indirectly on host cell microtubules.

Identifiants

pubmed: 36877064
doi: 10.1128/iai.00405-22
pmc: PMC10112248
doi:

Substances chimiques

Bacterial Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0040522

Références

EMBO J. 1996 Mar 1;15(5):964-77
pubmed: 8605892
Infect Immun. 2014 Jan;82(1):2-9
pubmed: 24126521
Mol Microbiol. 2011 Dec;82(5):1185-203
pubmed: 22014092
Comp Funct Genomics. 2012;2012:362104
pubmed: 22454599
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26784-26794
pubmed: 33055216
Cell Rep. 2017 May 16;19(7):1406-1417
pubmed: 28514660
Nature. 2009 Feb 5;457(7230):731-5
pubmed: 19060882
Infect Immun. 2016 Jun 23;84(7):2149-2158
pubmed: 27185791
Infect Immun. 2006 Dec;74(12):6965-72
pubmed: 17015457
J Vis Exp. 2013 Oct 23;(80):e50636
pubmed: 24192560
Biochem Biophys Res Commun. 2015 Jun 26;462(2):165-70
pubmed: 25944661
Traffic. 2006 Aug;7(8):950-65
pubmed: 16800847
Cell Host Microbe. 2015 Jul 8;18(1):109-21
pubmed: 26118995
Cell Microbiol. 2010 Sep 1;12(9):1235-49
pubmed: 20331642
Nat Rev Microbiol. 2016 Jun;14(6):385-400
pubmed: 27108705
Nat Commun. 2017 Mar 10;8:14729
pubmed: 28281536
BMC Genomics. 2011 Feb 16;12:109
pubmed: 21324157
Trends Microbiol. 2007 Nov;15(11):516-24
pubmed: 17983751
J Infect Dis. 2002 Feb 1;185(3):324-31
pubmed: 11807714
Infect Genet Evol. 2014 Apr;23:49-64
pubmed: 24509351
PLoS One. 2017 Jun 16;12(6):e0178856
pubmed: 28622339
PLoS One. 2013;8(2):e57090
pubmed: 23441233
Microbes Infect. 2002 Mar;4(3):333-40
pubmed: 11909744
Microb Cell. 2016 Sep 05;3(9):390-403
pubmed: 28357377
Infect Immun. 2015 Dec;83(12):4710-8
pubmed: 26416906
Cell Microbiol. 2012 Oct;14(10):1554-67
pubmed: 22646503
Front Cell Infect Microbiol. 2022 Jul 08;12:902210
pubmed: 35903198
Curr Protoc Microbiol. 2005 Jul;Chapter 11:Unit 11A.1
pubmed: 18770550
J Cell Biol. 2003 Sep 15;162(6):963-9
pubmed: 12975343
Nat Commun. 2019 Jun 21;10(1):2747
pubmed: 31227715
BMC Microbiol. 2009 Jan 05;9:2
pubmed: 19123944
Cell Host Microbe. 2015 May 13;17(5):716-25
pubmed: 25920978
Cell Host Microbe. 2017 Jan 11;21(1):113-121
pubmed: 28041929
mBio. 2016 Jul 12;7(4):
pubmed: 27406559
Sci Rep. 2019 Apr 16;9(1):6133
pubmed: 30992493
Int J Med Microbiol. 2014 Jul;304(5-6):542-53
pubmed: 24751478
Cell Microbiol. 2009 Jul;11(7):1064-73
pubmed: 19290915
Elife. 2017 Mar 02;6:
pubmed: 28252385
Mol Cell Biol. 2011 Dec;31(24):5011-22
pubmed: 21969606
FEMS Microbiol Lett. 2018 Oct 1;365(19):
pubmed: 30107569
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
PLoS Pathog. 2011 Jun;7(6):e1002092
pubmed: 21731489
Cell Rep. 2013 Jun 27;3(6):1921-31
pubmed: 23727243
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):12039-12044
pubmed: 29078338
PLoS Pathog. 2018 Mar 15;14(3):e1006911
pubmed: 29543918
Methods Mol Biol. 2011;731:93-103
pubmed: 21516400
mBio. 2021 Dec 21;12(6):e0239721
pubmed: 34903051
Nat Rev Mol Cell Biol. 2018 Jun;19(6):382-398
pubmed: 29662141
mBio. 2017 May 2;8(3):
pubmed: 28465429
Trends Microbiol. 2020 Nov;28(11):877-888
pubmed: 32591108
Cell Host Microbe. 2008 Aug 14;4(2):159-69
pubmed: 18692775
J Infect. 2003 Jul;47(1):45-51
pubmed: 12850162
Cell Rep. 2019 Mar 19;26(12):3380-3390.e5
pubmed: 30893609
FEMS Microbiol Rev. 2005 Nov;29(5):949-59
pubmed: 16043254
Cell Microbiol. 2021 Dec;23(12):e13397
pubmed: 34716742
J Bacteriol. 2012 Dec;194(23):6574-85
pubmed: 23042990
Infect Immun. 2008 Jun;76(6):2746-57
pubmed: 18391011
Lancet. 2014 Dec 13;384(9960):2142-52
pubmed: 25043452
J Cell Sci. 2015 Sep 15;128(18):3420-34
pubmed: 26220855
Front Cell Infect Microbiol. 2018 Jul 26;8:254
pubmed: 30094225
Microb Cell. 2019 Aug 21;6(9):414-449
pubmed: 31528632
Infect Immun. 2022 Jun 16;90(6):e0019022
pubmed: 35587198
Curr Opin Cell Biol. 2018 Feb;50:27-34
pubmed: 29438904
Cell. 2009 Apr 17;137(2):283-94
pubmed: 19379694
EMBO J. 2003 Oct 1;22(19):5003-14
pubmed: 14517239
Cells. 2022 Jan 21;11(3):
pubmed: 35159164
PLoS One. 2014 Jun 23;9(6):e100763
pubmed: 24955832
J Bacteriol. 2010 Oct;192(19):5093-102
pubmed: 20675479
Sci Rep. 2019 Dec 20;9(1):19485
pubmed: 31862969
Infect Immun. 2010 Sep;78(9):3678-88
pubmed: 20605986
Protein Expr Purif. 2005 May;41(1):207-34
pubmed: 15915565
Traffic. 2011 Jul;12(7):854-66
pubmed: 21477082
Medicine (Baltimore). 2016 Mar;95(13):e3077
pubmed: 27043670

Auteurs

Maria Pequito Luís (MP)

Associate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.
Department of Life Sciences, UCIBIO, Applied Molecular Biosciences Unit, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.

Inês Serrano Pereira (IS)

Associate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.
Department of Life Sciences, UCIBIO, Applied Molecular Biosciences Unit, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.

Joana N Bugalhão (JN)

Associate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.
Department of Life Sciences, UCIBIO, Applied Molecular Biosciences Unit, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.

Catarina N Simões (CN)

Department of Life Sciences, UCIBIO, Applied Molecular Biosciences Unit, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.
Faculty of Sciences, University of Lisbon, Lisbon, Portugal.

Cristiano Mota (C)

Associate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.
Department of Chemistry, UCIBIO, Applied Molecular Biosciences Unit, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.

Maria João Romão (MJ)

Associate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.
Department of Chemistry, UCIBIO, Applied Molecular Biosciences Unit, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.

Luís Jaime Mota (LJ)

Associate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.
Department of Life Sciences, UCIBIO, Applied Molecular Biosciences Unit, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH